[go: up one dir, main page]

ES2128353T3 - Composicion topica que contiene penciclovir. - Google Patents

Composicion topica que contiene penciclovir.

Info

Publication number
ES2128353T3
ES2128353T3 ES92914132T ES92914132T ES2128353T3 ES 2128353 T3 ES2128353 T3 ES 2128353T3 ES 92914132 T ES92914132 T ES 92914132T ES 92914132 T ES92914132 T ES 92914132T ES 2128353 T3 ES2128353 T3 ES 2128353T3
Authority
ES
Spain
Prior art keywords
composition containing
penciclovir
topic composition
containing penciclovir
topic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92914132T
Other languages
English (en)
Inventor
Alan John Goodall
Hazel-Ann Griffiths
Joshua Oduro-Yeboah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2128353T3 publication Critical patent/ES2128353T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)

Abstract

UNA FORMULACION FARMACEUTICA TOPICA ACUOSA O LIPOSOLUBLE PARA EL TRATAMIENTO DE INFECCIONES VIRICAS DE LA PIEL O DE LAS MUCOSAS, COMPRENDE AL MENOS UN 30 % DE GLICOL PROPILENO, AL MENOS 0''75 % DE PENCICLOVIR Y DE 0''5 % A 1 % DE CETOMACROGOL 1000.
ES92914132T 1991-07-11 1992-07-03 Composicion topica que contiene penciclovir. Expired - Lifetime ES2128353T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114939A GB9114939D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ES2128353T3 true ES2128353T3 (es) 1999-05-16

Family

ID=10698164

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92914132T Expired - Lifetime ES2128353T3 (es) 1991-07-11 1992-07-03 Composicion topica que contiene penciclovir.

Country Status (18)

Country Link
EP (1) EP0593562B1 (es)
JP (1) JP2865867B2 (es)
KR (1) KR100245016B1 (es)
AT (1) ATE177638T1 (es)
AU (2) AU2230792A (es)
CA (1) CA2113080C (es)
DE (1) DE69228686T2 (es)
DK (1) DK0593562T3 (es)
ES (1) ES2128353T3 (es)
GB (1) GB9114939D0 (es)
GR (1) GR3029886T3 (es)
IE (1) IE922263A1 (es)
MX (1) MX9204030A (es)
NZ (1) NZ243490A (es)
PT (1) PT100670B (es)
TW (1) TW328049B (es)
WO (1) WO1993000905A1 (es)
ZA (1) ZA925130B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
CN109481674A (zh) * 2018-11-14 2019-03-19 大连亚维药业有限公司 一种生物无菌乳膏药物的生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
ZA925130B (en) 1993-05-05
AU698847B2 (en) 1998-11-12
ATE177638T1 (de) 1999-04-15
JPH06508845A (ja) 1994-10-06
DK0593562T3 (da) 1999-09-27
IE922263A1 (en) 1993-01-13
CA2113080C (en) 2003-02-25
EP0593562A1 (en) 1994-04-27
WO1993000905A1 (en) 1993-01-21
MX9204030A (es) 1993-02-01
CA2113080A1 (en) 1993-01-21
NZ243490A (en) 1995-03-28
DE69228686D1 (de) 1999-04-22
JP2865867B2 (ja) 1999-03-08
PT100670B (pt) 1999-07-30
GB9114939D0 (en) 1991-08-28
AU4040195A (en) 1996-02-22
AU2230792A (en) 1993-02-11
EP0593562B1 (en) 1999-03-17
TW328049B (en) 1998-03-11
HK1012242A1 (en) 1999-07-30
DE69228686T2 (de) 1999-09-09
GR3029886T3 (en) 1999-07-30
KR100245016B1 (ko) 2000-03-02
PT100670A (pt) 1993-10-29

Similar Documents

Publication Publication Date Title
TR199903053T2 (xx) Benzimidazol t�revleri.
FI875272L (fi) Baerarloesningsmedelssystem i tvao fas.
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
FI900052A0 (fi) Kompositioner och behandlingsmetoder foer hemorrojder och annat.
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
BG101118A (en) Therapeutical compounds
AR010995A1 (es) Uso de la mupirocina, sales o esteres de la misma en la obtencion de medicamentos administrables via nasal y formulaciones farmaceuticas inclusiveformulaciones farmaceuticas administrables via nasal.
FI944770A0 (fi) Neurotensiiniin vaikuttavia substituoituja 1-naftyylipyratsoli-3-karboksiamideja, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ES2064166T3 (es) Composiciones conteniendo propionato de fluticasona y oxiconazol o sus sales para administracion topica.
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
ES2128353T3 (es) Composicion topica que contiene penciclovir.
MY110074A (en) Pharmacuetical formulation.
KR910004186A (ko) 제약학적 배합물
ES2189886T3 (es) Composicion farmaceutica para aplicacion topica.
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
DE3877002D1 (de) Pharmazeutische zusammensetzung.
MX9303985A (es) Nucleosidos terapeuticos.
DE69902925D1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
ATE277622T1 (de) Arzneimittel enthaltend xenogene oligo- oder/und polyribonukleotide
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
CO5031290A1 (es) Formulacion lo
SE8802257D0 (sv) Antimikrobiell komposition
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
IT1247695B (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 593562

Country of ref document: ES